IRIS Accounts Production v24.3.2.46 08451815 director 1.6.23 31.5.24 31.5.24 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh084518152023-05-31084518152024-05-31084518152023-06-012024-05-31084518152022-05-31084518152022-06-012023-05-31084518152023-05-3108451815ns15:EnglandWales2023-06-012024-05-3108451815ns14:PoundSterling2023-06-012024-05-3108451815ns10:Director12023-06-012024-05-3108451815ns10:PrivateLimitedCompanyLtd2023-06-012024-05-3108451815ns10:SmallEntities2023-06-012024-05-3108451815ns10:AuditExempt-NoAccountantsReport2023-06-012024-05-3108451815ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-3108451815ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-3108451815ns10:FullAccounts2023-06-012024-05-310845181512023-06-012024-05-3108451815ns10:OrdinaryShareClass12023-06-012024-05-3108451815ns5:CurrentFinancialInstruments2024-05-3108451815ns5:CurrentFinancialInstruments2023-05-3108451815ns5:ShareCapital2024-05-3108451815ns5:ShareCapital2023-05-3108451815ns5:RetainedEarningsAccumulatedLosses2024-05-3108451815ns5:RetainedEarningsAccumulatedLosses2023-05-3108451815ns10:RegisteredOffice2023-06-012024-05-3108451815ns5:IntangibleAssetsOtherThanGoodwill2023-06-012024-05-3108451815ns5:PlantMachinery2023-06-012024-05-3108451815ns5:FurnitureFittings2023-06-012024-05-3108451815ns5:ComputerEquipment2023-06-012024-05-3108451815ns5:NetGoodwill2023-05-3108451815ns5:NetGoodwill2023-06-012024-05-3108451815ns5:NetGoodwill2024-05-3108451815ns5:NetGoodwill2023-05-3108451815ns5:PlantMachinery2023-05-3108451815ns5:FurnitureFittings2023-05-3108451815ns5:ComputerEquipment2023-05-3108451815ns5:PlantMachinery2024-05-3108451815ns5:FurnitureFittings2024-05-3108451815ns5:ComputerEquipment2024-05-3108451815ns5:PlantMachinery2023-05-3108451815ns5:FurnitureFittings2023-05-3108451815ns5:ComputerEquipment2023-05-3108451815ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-3108451815ns5:WithinOneYearns5:CurrentFinancialInstruments2023-05-3108451815ns5:AcceleratedTaxDepreciationDeferredTax2024-05-3108451815ns5:AcceleratedTaxDepreciationDeferredTax2023-05-3108451815ns5:DeferredTaxation2023-05-3108451815ns5:DeferredTaxation2023-06-012024-05-3108451815ns5:DeferredTaxation2024-05-3108451815ns10:OrdinaryShareClass12024-05-31084518151ns10:Director12023-05-31084518151ns10:Director12022-05-31084518151ns10:Director12023-06-012024-05-31084518151ns10:Director12022-06-012023-05-31084518151ns10:Director12024-05-31084518151ns10:Director12023-05-31
REGISTERED NUMBER: 08451815 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 MAY 2024

FOR

WADHURST & CROWBOROUGH PHYSIOTHERAPY
& SPORTS INJURY CLINIC LIMITED

WADHURST & CROWBOROUGH PHYSIOTHERAPY
& SPORTS INJURY CLINIC LIMITED (REGISTERED NUMBER: 08451815)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024










Page

Balance Sheet 1

Notes to the Financial Statements 3


WADHURST & CROWBOROUGH PHYSIOTHERAPY
& SPORTS INJURY CLINIC LIMITED (REGISTERED NUMBER: 08451815)

BALANCE SHEET
31 MAY 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 5 - -
Tangible assets 6 1,831 3,346
1,831 3,346

CURRENT ASSETS
Stocks 12,331 8,048
Debtors 7 63,690 50,472
Cash at bank 55,113 54,679
131,134 113,199
CREDITORS
Amounts falling due within one year 8 22,471 19,152
NET CURRENT ASSETS 108,663 94,047
TOTAL ASSETS LESS CURRENT
LIABILITIES

110,494

97,393

PROVISIONS FOR LIABILITIES 9 458 837
NET ASSETS 110,036 96,556

CAPITAL AND RESERVES
Called up share capital 10 1 1
Retained earnings 110,035 96,555
SHAREHOLDERS' FUNDS 110,036 96,556

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

WADHURST & CROWBOROUGH PHYSIOTHERAPY
& SPORTS INJURY CLINIC LIMITED (REGISTERED NUMBER: 08451815)

BALANCE SHEET - continued
31 MAY 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 18 February 2025 and were signed by:





Mrs S Van Kessel - Director


WADHURST & CROWBOROUGH PHYSIOTHERAPY
& SPORTS INJURY CLINIC LIMITED (REGISTERED NUMBER: 08451815)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024


1. STATUTORY INFORMATION

Wadhurst & Crowborough Physiotherapy & Sports Injury Clinic Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 08451815

Registered office: Pharmacy Chambers
High Street
Wadhurst
East Sussex
TN5 6AP

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on cost
Equipment - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

WADHURST & CROWBOROUGH PHYSIOTHERAPY
& SPORTS INJURY CLINIC LIMITED (REGISTERED NUMBER: 08451815)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024


3. ACCOUNTING POLICIES - continued

Financial instruments
The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities, like trade and other accounts receivable and payable, loans from banks and other third parties and loans to / from related parties.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at the present value of the future cash flows and subsequently measured at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade payables or receivables, are measured, initially and subsequently, at the undiscounted transaction price less any impairment.

If the arrangements of a short term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of the estimated cash flows discounted at the asset's original effective rate.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the reporting date.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet and measured as detailed above.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

Finance costs are charged to the profit and loss over the term of the financial asset / liability using the effective interest method so that the amount charged is at a constant rate on the carrying amount.


WADHURST & CROWBOROUGH PHYSIOTHERAPY
& SPORTS INJURY CLINIC LIMITED (REGISTERED NUMBER: 08451815)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024


3. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2023 - 3 ) .

WADHURST & CROWBOROUGH PHYSIOTHERAPY
& SPORTS INJURY CLINIC LIMITED (REGISTERED NUMBER: 08451815)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024


5. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 June 2023 101,500
Disposals (101,500 )
At 31 May 2024 -
AMORTISATION
At 1 June 2023 101,500
Eliminated on disposal (101,500 )
At 31 May 2024 -
NET BOOK VALUE
At 31 May 2024 -
At 31 May 2023 -

6. TANGIBLE FIXED ASSETS
Fixtures
Plant and and
machinery fittings Equipment Totals
£    £    £    £   
COST
At 1 June 2023
and 31 May 2024 6,370 5,181 11,358 22,909
DEPRECIATION
At 1 June 2023 4,354 4,645 10,564 19,563
Charge for year 504 239 772 1,515
At 31 May 2024 4,858 4,884 11,336 21,078
NET BOOK VALUE
At 31 May 2024 1,512 297 22 1,831
At 31 May 2023 2,016 536 794 3,346

WADHURST & CROWBOROUGH PHYSIOTHERAPY
& SPORTS INJURY CLINIC LIMITED (REGISTERED NUMBER: 08451815)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024


7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 17,345 10,079
Amounts receivable on contracts 26,607 24,190
Director's current account 18,015 14,982
Prepayments and accrued income 1,723 1,221
63,690 50,472

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 7,230 7,256
Corporation tax 13,624 10,561
Accrued expenses 1,617 1,335
22,471 19,152

9. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax
Accelerated capital allowances 458 837

Deferred
tax
£   
Balance at 1 June 2023 837
Provided during year (379 )
Balance at 31 May 2024 458

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1 Ordinary £1 1 1

WADHURST & CROWBOROUGH PHYSIOTHERAPY
& SPORTS INJURY CLINIC LIMITED (REGISTERED NUMBER: 08451815)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024


11. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 May 2024 and 31 May 2023:

2024 2023
£    £   
Mrs S Van Kessel
Balance outstanding at start of year 14,982 15,655
Amounts advanced 73,318 8,867
Amounts repaid (70,286 ) (9,540 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 18,014 14,982